Open AccessAdrenal Involvement in an SLE Patient with Antiphospholipid Syndrome
Author(s) -
M Mejía-Torres,
I Carrión-Barberà,
Salman-Monte TC,
J Monfort
Publication year - 2021
Publication title -
annals of hematology and oncology
Language(s) - English
Resource type - Journals
ISSN - 2375-7965
DOI - 10.26420/annhematoloncol.2021.1363
Subject(s) - medicine , antiphospholipid syndrome , hyponatremia , catastrophic antiphospholipid syndrome , complication , disease , adrenal insufficiency , pediatrics , intensive care medicine , thrombosis
Addison disease related to SLE and mostly to Antiphospholipid Syndrome (APS) is a rare condition that should be suspected in patients presenting with abdominal complaints, fever, hypotension and hyponatremia [1-3]. Its prevalence remains unknown such as its time of onset once SLE or APS are diagnosed [3]. Nowadays, there is not enough evidence for recommending systematic screening regarding this involvement. Its estimated mortality is 3.81% [1]. Nevertheless, under correct treatment, long-term survival is quite favourable [4]. Our main objective is to remind a very uncommon but life-threatening complication that might affect patients with Antiphospholipid Syndrome (APS) associated to SLE.